APG Asset Management N.V. Has $105.95 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

APG Asset Management N.V. boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 260.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 472,410 shares of the financial services provider’s stock after purchasing an additional 341,238 shares during the quarter. APG Asset Management N.V. owned about 0.13% of CME Group worth $105,947,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. increased its holdings in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the period. Dunhill Financial LLC grew its position in CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares in the last quarter. New Age Alpha Advisors LLC increased its stake in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 43 shares during the period. Financial Life Planners acquired a new position in CME Group in the 4th quarter valued at approximately $32,000. Finally, Knuff & Co LLC bought a new stake in shares of CME Group in the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Down 0.8 %

NASDAQ:CME opened at $252.37 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $273.42. The firm has a market capitalization of $90.94 billion, a P/E ratio of 26.10, a P/E/G ratio of 6.76 and a beta of 0.43. The stock’s fifty day simple moving average is $252.91 and its 200-day simple moving average is $237.72.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were issued a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 annualized dividend and a dividend yield of 1.98%. CME Group’s payout ratio is 51.71%.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of recent research reports. Morgan Stanley upped their target price on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Bank of America upped their target price on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research note on Wednesday, April 2nd. Erste Group Bank upgraded shares of CME Group to a “strong-buy” rating in a research note on Monday, March 17th. Finally, Piper Sandler upped their price objective on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $242.60.

Insider Activity at CME Group

In related news, Director Howard J. Siegel sold 10,000 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now directly owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock worth $6,871,496 in the last quarter. Corporate insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.